~~<i id='153C41DBE2'><strike id='153C41DBE2'><tt id='153C41DBE2'><pre id='153C41DBE2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：comprehensive 2025-08-28 13:04:25 - browse：174

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Senate panel passes drug pricing bills, but drops one PBM reform

hotspot

entertainment

explore

hotspot

entertainment

focus

AdobeTheFoodandDrugAdministrationonTuesdayapprovedbrexanolone,thefirstdrugspecificallytargetedtotrea

WSS

Readout LOUD podcast: How biotech is using artificial intelligence

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Why did Pfizer dish out millions for a Super Bowl ad?

'Revelatory' study finds a smoking impact that remains after quitting

FDA approves first new drug developed for postpartum depression

A disappointing year of Humira biosimilars

entertainment

hotspot

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Key House Republican on health care plans exit from Congress

Tori Bowie and the unacceptable rates of Black maternal death

Biogen Alzheimer’s drug launch off to slow start

After affirmative action ruling, medical educators look to 'holistic review'

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Dobbs anniversary: the lost opportunity of abortion as health care

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Supreme Court strikes down use of affirmative action

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

entertainment

Inside the rise of 'mukbang' eating videos

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Medical mystery: When a cough is not just a cough

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Medicare threatens to cut off funding for HCA's Mission hospital

Inside the rise of 'mukbang' eating videos

explore

hotspot

entertainment

focus